Pro-Dex, Inc. (PDEX)
61.40
-0.70
(-1.13%)
USD |
NASDAQ |
Sep 01, 16:00
61.99
+0.59
(+0.96%)
Pre-Market: 08:57
Pro-Dex Cash from Operations (Annual) : -1.682M for June 30, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| June 30, 2025 | -1.682M |
| June 30, 2024 | 6.224M |
| June 30, 2023 | 5.462M |
| June 30, 2022 | -0.847M |
| June 30, 2021 | -2.078M |
| June 30, 2020 | 4.945M |
| June 30, 2019 | 3.326M |
| June 30, 2018 | 3.096M |
| June 30, 2017 | 3.235M |
| June 30, 2016 | -1.178M |
| June 30, 2015 | -0.775M |
| June 30, 2014 | -0.329M |
| June 30, 2013 | -1.271M |
| June 30, 2012 | 0.045M |
| Date | Value |
|---|---|
| June 30, 2011 | 2.898M |
| June 30, 2010 | 3.24M |
| June 30, 2009 | 1.718M |
| June 30, 2008 | 2.018M |
| June 30, 2007 | 1.48M |
| June 30, 2006 | 0.055M |
| June 30, 2005 | 0.557M |
| June 30, 2004 | 2.054M |
| June 30, 2003 | 0.503M |
| June 30, 2002 | -1.757M |
| June 30, 2001 | 0.616M |
| June 30, 2000 | 1.993M |
| June 30, 1999 | -0.336M |
| June 30, 1998 | 2.099M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Abbott Laboratories | 9.566B |
| AngioDynamics, Inc. | 3.089M |
| Alphatec Holdings, Inc. | 45.23M |
| AtriCure, Inc. | 57.33M |
| Baxter International, Inc. | 845.00M |